Imatinib and tyrosine kinase inhibition, in the management of BCR-ABL negative myeloproliferative disorders

The chronic myeloproliferative disorders (MPDs) include the spectrum of clonal hematopoietic stem cell disorders whose phenotype derive from the primary cell expanded in a proliferative state. The MPDs (which include polycythemia vera (PV), essential thrombocythemia (ET), chronic eosinophilic leukem...

Descripción completa

Detalles Bibliográficos
Autor principal: Mesa, Ruben A
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721304/
https://www.ncbi.nlm.nih.gov/pubmed/19707323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721304/
https://www.ncbi.nlm.nih.gov/pubmed/19707323

Ejemplares similares